Yesterday WHO and UNAIDS welcomed ground breaking proof of concept study results for tenofovir vaginal gel which has shown a reduction in the risk of HIV infections in women (read more).
Here you can find resources and background information on the study:
CAPRISA website
Press release
Study backgrounder (PDF, 83 KB)
Questions and Answers (PDF, 109 KB)
Collection of factsheet summaries (PDF, 117 KB)
Factsheet on effectiveness (PDF, 105 KB)
Factsheet on safety (PDF, 133 KB)
Factsheet on adherence (PDF, 107 KB)
Factsheet on HSV-2 (PDF, 104 KB)
Factsheet on drug resistance (PDF, 100 KB)
Factsheet on pregnancy (PDF, 105 KB)